logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Chemical Intermediates > Adefovir CAS 106941-25-7 Chemical Intermediates

Adefovir CAS 106941-25-7 Chemical Intermediates

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 106941-25-7

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:

Adefovir CAS 106941-25-7

,

CAS 106941-25-7

CAS NO::
106941-25-7
Appearance::
White To Off-white Powder
Molecular Formula::
C8H12N5O4P
Molecular Weight::
273.18600
EINECS NO::
600-789-7
MDL NO::
MFCD00866943
CAS NO::
106941-25-7
Appearance::
White To Off-white Powder
Molecular Formula::
C8H12N5O4P
Molecular Weight::
273.18600
EINECS NO::
600-789-7
MDL NO::
MFCD00866943
Adefovir CAS 106941-25-7 Chemical Intermediates

Product Description:

Product Name: Adefovir CAS NO: 106941-25-7

 

 

Synonyms:

treatment Adefovir;

Tenofovir Desmeth-yl Impurity;

2-(6-amino-9h-purin-;Adefovir dipivox (PMEA);

 

 

Chemical & Physical Properties:

Appearance: White to off-white powder

Assay :≥99.0%

Density: 1.88

Boiling Point: 632.5℃ at 760 mmHg

Melting Point: >260℃

Flash Point: 336.3℃

 

 

Safety Information:

Hazard Class: 8

Safety Statement: S26

HS Code: 2933990090

WGK Germany: 2

Packing Group: III

RIDADR: UN 2585 8/PG 3

Risk Statements: R36/37/38

Hazard Code: Xi

Hazard Declaration: H301

Symbol: GHS06

Caution Statements: P301 + P310

Signal Word: Danger

 

 

Adefovir (Trade name: Preveon, Hepsera) is a prescription drug used for the treatment of chronic infections of hepatitis B virus. It can be formulated as the pivoxil prodrug adefovir dipivoxil. However, it shows no effect against HIV-1. As a orally administrated acyclic nucleotide analog reverse transcriptase inhibitor, it blocking the reproduction of HBV through inhibiting the reverse transcriptase in the body. One of its advantages over another anti-HBV drug, lamivudine is that it is much harder for the virus to develop resistance to it.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.